Long-term follow-up of leucoderma patients treated with transplants of autologous cultured melanocytes, ultrathin epidermal sheets and basal cell layer suspension

被引:100
作者
Olsson, MJ [1 ]
Juhlin, L [1 ]
机构
[1] Univ Hosp, Sect Dermatol & Venereol, Dept Med Sci, SE-75185 Uppsala, Sweden
关键词
halo naevi; leucoderma; melanocytes; piebaldism; transplantations; vitiligo;
D O I
10.1046/j.1365-2133.2002.04837.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background In vitiligo and piebaldism the lack of melanin in the epidermis is due to the fact that melanocytes are missing. The patients suffer psychologically and the white areas have lost the part of the skin barrier protection normally provided by the melanocytes. Medical treatments are ineffective in many of the patients, and surgical methods have therefore been developed. Objectives It is important to investigate the long-term results and factors that might influence the outcome of melanocyte transplantations in order to form a basis for guidance in the selection of patients who will benefit most from the treatments. Methods A follow-up of 132 patients who had been treated by transplantation on 176 occasions in total, 1-7 years previously, was carried out by questionnaires and clinical examinations. We investigated the responses in five types of leucoderma to three different transplantation methods: autologous cultured melanocytes, ultrathin epidermal sheets and basal layer cell suspension. Results Stable types of leucoderma, i.e. segmental vitiligo and piebaldism, responded in most cases with 100% repigmentation, regardless of the surgical method used. For these types of leucoderma surgery seems to be the method of choice. The largest group, vitiligo vulgaris, was thoroughly scrutinized and three statistical models were used to analyse the data. The ultrathin epidermal sheet method gave somewhat better overall results, but was the method that gave the worst outcome in knee and elbow areas, emphasizing the importance of the right choice of method depending on the anatomical location to be treated. Irrespective of the method, fingers and elbows were the most difficult areas to repigment. The trunk and the arms and legs (not including elbows and knees) responded best. Patients with increasing and or extensive vitiligo vulgaris more often showed incomplete repigmentation. They also had a lower chance of retaining their repigmentation compared with those with less extensive vitiligo. Patients in whom untreated white lesions had increased in recent years tended to respond less well to transplantation compared with patients with unchanged or decreased lesions. Within the vitiligo vulgaris group, patients with short disease duration or with small total vitiligo area responded best to transplantation. The subgroup of vitiligo vulgaris patients with hypothyroidism tend to respond less well to the transplantation and they were generally older at vitiligo onset. This information is of great importance for the selection of patients and when informing about the chances of improvement after transplantation. Slight hyperpigmentation was common, especially when ultrathin epidermal sheets had been used. No scars or indurations were seen in treated areas. Conclusions Transplantations are the methods of choice in stable types of leucoderma. Progressive, widespread vitiligo vulgaris should never be selected for transplantation.
引用
收藏
页码:893 / 904
页数:12
相关论文
共 18 条
[1]   Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo [J].
Ameen, M ;
Exarchou, V ;
Chu, AC .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 145 (03) :476-479
[2]   Tyrosinase as an autoantigen in patients with vitiligo [J].
Baharav, E ;
Merimski, O ;
Shoenfeld, Y ;
Zigelman, R ;
Gilbrud, B ;
Yecheskel, G ;
Youinou, P ;
Fishman, P .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01) :84-88
[3]   Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study [J].
Ermis, O ;
Alpsoy, E ;
Cetin, L ;
Yilmaz, E .
BRITISH JOURNAL OF DERMATOLOGY, 2001, 145 (03) :472-475
[4]   ANTIBODIES TO MELANOCYTES - OCCURRENCE IN PATIENTS WITH VITILIGO AND CHRONIC MUCOCUTANEOUS CANDIDIASIS [J].
HOWANITZ, N ;
NORDLUND, JL ;
LERNER, AB ;
BYSTRYN, JC .
ARCHIVES OF DERMATOLOGY, 1981, 117 (11) :705-708
[5]   Detection of tyrosinase autoantibodies in patients with vitiligo using S-35-labeled recombinant human tyrosinase in a radioimmunoassay [J].
Kemp, EH ;
Gawkrodger, DJ ;
MacNeil, S ;
Watson, PF ;
Weetman, AP .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 109 (01) :69-73
[6]  
Kemp EH, 1999, BRIT J DERMATOL, V140, P73
[7]  
Mahmoud Fadia, 1998, Journal of Dermatology (Tokyo), V25, P637
[8]   Nonsurgical repigmentation therapies in vitiligo - Meta-analysis of the literature [J].
Njoo, MD ;
Spuls, PI ;
Bos, JD ;
Westerhof, W ;
Bossuyt, PMM .
ARCHIVES OF DERMATOLOGY, 1998, 134 (12) :1532-1540
[9]   A systematic review of autologous transplantation methods in vitiligo [J].
Njoo, MD ;
Westerhof, W ;
Bos, JD ;
Bossuyt, PMM .
ARCHIVES OF DERMATOLOGY, 1998, 134 (12) :1543-1549
[10]   High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo [J].
Ogg, GS ;
Dunbar, PR ;
Romero, P ;
Chen, JL ;
Cerundolo, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (06) :1203-1208